{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:08:41Z","timestamp":1791425321663,"version":"4.3.3"},"reference-count":43,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Danish Cardiovascular Academy","award":["PD2Y-2022002-DCA"],"award-info":[{"award-number":["PD2Y-2022002-DCA"]}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF20SA0067242"],"award-info":[{"award-number":["NNF20SA0067242"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007405","name":"Danish Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Monitoring trends in mortality of atrial fibrillation (AF) in comparison with other major cardiovascular conditions indirectly gives insights into the relative progress in management. We examined trends in relative survival metrics of AF compared with heart failure (HF), myocardial infarction (MI), and stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This nationwide cohort study included all individuals newly diagnosed with AF, HF, MI, or stroke between 2000 and 2021. Relative survival and excess mortality rates were examined at 1, 5, and 10 years after diagnosis. The general Danish population served as the comparator, adjusted for age, sex, and calendar year. The study included 364 199 patients with AF, 242 570 with HF, 172 552 with MI, and 281 407 with stroke. For relative survival, AF had the smallest average improvement over calendar years at 1 and 5 years after diagnosis (0.35% and 0.58% per year), while at 10 years, AF, MI, and stroke had the smallest average improvements (0.77, 0.72, and 0.80% per year). For excess mortality rate, AF and stroke had the smallest average improvements over calendar years at 1 year (\u22121.02 and \u22120.96 additional deaths per 1000 person-years per year) and MI at 5 years (\u22120.13 additional deaths per 1000 person-years per year). No average improvement was observed in the 10-year excess mortality rate for MI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Atrial fibrillation was the condition or was among those with the smallest improvement in relative survival, and AF and stroke showed the smallest improvement in 1-year excess mortality. The findings highlight the need for renewed efforts in prevention, early detection, and post-acute care for these conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwaf371","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T07:40:30Z","timestamp":1750750830000},"source":"Crossref","is-referenced-by-count":2,"title":["Comparison of excess mortality between atrial fibrillation, heart failure, myocardial infarction, and stroke: trends over 2000\u201322"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0558-8483","authenticated-orcid":false,"given":"Nicklas","family":"Vinter","sequence":"first","affiliation":[{"name":"Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University , DK-9260 Gistrup ,","place":["Denmark"]},{"name":"Department of Cardiology, Regional Hospital Central Jutland , DK-8800 Viborg ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2787-0271","authenticated-orcid":false,"given":"S\u00f8ren Paaske","family":"Johnsen","sequence":"additional","affiliation":[{"name":"Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University , DK-9260 Gistrup ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University , DK-9260 Gistrup ,","place":["Denmark"]},{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital , Liverpool L14 3PE ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4076-2336","authenticated-orcid":false,"given":"Emelia J","family":"Benjamin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02118 , Boston, MA 02118 ,","place":["USA"]},{"name":"Department of Epidemiology, Boston University School of Public Health , Boston, MA 02118 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9215-9796","authenticated-orcid":false,"given":"Lars","family":"Frost","sequence":"additional","affiliation":[{"name":"Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University , DK-9260 Gistrup ,","place":["Denmark"]},{"name":"Department of Cardiology, Regional Hospital Central Jutland , DK-8800 Viborg ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3028-4900","authenticated-orcid":false,"given":"Ludovic","family":"Trinquart","sequence":"additional","affiliation":[{"name":"Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University , DK-9260 Gistrup ,","place":["Denmark"]},{"name":"Tufts Clinical and Translational Science Institute, Tufts University , Boston, MA 02111 ,","place":["USA"]},{"name":"Institute for Clinical Research and Health Policy Studies, Tufts Medical Center , Boston, MA 02111 ,","place":["USA"]},{"name":"Department of Biostatistics, Boston University School of Public Health , Boston, MA 02118 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"2025071421513865600_zwaf371-B1","doi-asserted-by":"crossref","first-page":"e077209","DOI":"10.1136\/bmj-2023-077209","article-title":"Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study","volume":"385","author":"Vinter","year":"2024","journal-title":"BMJ"},{"key":"2025071421513865600_zwaf371-B2","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2025071421513865600_zwaf371-B3","doi-asserted-by":"crossref","first-page":"l223","DOI":"10.1136\/bmj.l223","article-title":"Trends in survival after a diagnosis of heart failure in the United Kingdom 2000\u20132017: population based cohort study","volume":"364","author":"Taylor","year":"2019","journal-title":"Bmj"},{"key":"2025071421513865600_zwaf371-B4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/jamacardio.2019.3593","article-title":"Temporal trends and patterns in mortality after incident heart failure: a longitudinal analysis of 86\u202f000 individuals","volume":"4","author":"Conrad","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2025071421513865600_zwaf371-B5","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1093\/eurheartj\/ehad571","article-title":"Temporal trends of cause-specific mortality after diagnosis of atrial fibrillation","volume":"44","author":"Wu","year":"2023","journal-title":"Eur Heart J"},{"key":"2025071421513865600_zwaf371-B6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijcard.2016.09.071","article-title":"30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death","volume":"225","author":"Schmidt","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025071421513865600_zwaf371-B7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"key":"2025071421513865600_zwaf371-B8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijcard.2016.01.196","article-title":"Trends in incidence and prevalence of hospitalization for atrial fibrillation and associated mortality in Western Australia, 1995\u20132010","volume":"208","author":"Briffa","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025071421513865600_zwaf371-B9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ehjqcco\/qcae007","article-title":"Trends in atrial fibrillation-related mortality in Europe, 2008\u20132019","volume":"10","author":"Zuin","year":"2024","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025071421513865600_zwaf371-B10","doi-asserted-by":"crossref","first-page":"e020163","DOI":"10.1161\/JAHA.120.020163","article-title":"Trends in cardiovascular mortality related to atrial fibrillation in the United States, 2011 to 2018","volume":"10","author":"Tanaka","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2025071421513865600_zwaf371-B11","doi-asserted-by":"crossref","first-page":"m2724","DOI":"10.1136\/bmj.m2724","article-title":"Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study","volume":"370","author":"Vinter","year":"2020","journal-title":"BMJ"},{"key":"2025071421513865600_zwaf371-B12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12916-021-02037-x","article-title":"Temporal trends in cause-specific mortality among individuals with newly diagnosed atrial fibrillation in the Framingham Heart Study","volume":"19","author":"Kornej","year":"2021","journal-title":"BMC Med"},{"key":"2025071421513865600_zwaf371-B13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/eurheartj\/ehn079","article-title":"Relative survival: what can cardiovascular disease learn from cancer?","volume":"29","author":"Nelson","year":"2008","journal-title":"Eur Heart J"},{"key":"2025071421513865600_zwaf371-B14","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1002\/sim.3064","article-title":"Flexible parametric models for relative survival, with application in coronary heart disease","volume":"26","author":"Nelson","year":"2007","journal-title":"Stat Med"},{"key":"2025071421513865600_zwaf371-B15","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/ije\/dyv105","article-title":"Data resource profile: the human mortality database (HMD)","volume":"44","author":"Barbieri","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2025071421513865600_zwaf371-B16","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med"},{"key":"2025071421513865600_zwaf371-B17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ije\/dyz268","article-title":"Marginal measures and causal effects using the relative survival framework","volume":"49","author":"Syriopoulou","year":"2020","journal-title":"Int J Epidemiol"},{"key":"2025071421513865600_zwaf371-B18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.amjmed.2014.10.030","article-title":"Decade-long trends in atrial fibrillation incidence and survival: a community study","volume":"128","author":"Chamberlain","year":"2015","journal-title":"Am J Med"},{"key":"2025071421513865600_zwaf371-B19","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.amjcard.2017.08.014","article-title":"Temporal trends in the incidence, prevalence, and survival of patients with atrial fibrillation from 2004 to 2016","volume":"120","author":"Williams","year":"2017","journal-title":"Am J Cardiol"},{"key":"2025071421513865600_zwaf371-B20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2147\/CLEP.S443473","article-title":"The Danish atrial fibrillation registry: a multidisciplinary national pragmatic initiative for monitoring and supporting quality of care based on data retrieved from administrative registries","volume":"15","author":"Frost","year":"2023","journal-title":"Clin Epidemiol"},{"key":"2025071421513865600_zwaf371-B21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"2025071421513865600_zwaf371-B22","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.hrthm.2020.02.030","article-title":"Generalizability of the CASTLE-AF trial: catheter ablation for patients with atrial fibrillation and heart failure in routine practice","volume":"17","author":"Noseworthy","year":"2020","journal-title":"Heart Rhythm"},{"key":"2025071421513865600_zwaf371-B23","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1055\/a-2434-9244","article-title":"The 2024 European society of cardiology guidelines for diagnosis and management of atrial fibrillation: a viewpoint from a practicing clinician's perspective","volume":"124","author":"Potpara","year":"2024","journal-title":"Thromb Haemost"},{"key":"2025071421513865600_zwaf371-B24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.amjmed.2023.09.012","article-title":"Impact of unhealthy lifestyles on patients with atrial fibrillation at low risk of stroke: a nationwide cohort study","volume":"137","author":"Kwon","year":"2024","journal-title":"Am J Med"},{"key":"2025071421513865600_zwaf371-B25","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/s41591-023-02567-2","article-title":"Recent successes in heart failure treatment","volume":"29","author":"Lam","year":"2023","journal-title":"Nat Med"},{"key":"2025071421513865600_zwaf371-B26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.31083\/j.rcm2309297","article-title":"Current status and future direction of antithrombotic therapy for patients with STEMI undergoing primary PCI","volume":"23","author":"Vogel","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"2025071421513865600_zwaf371-B27","first-page":"741","article-title":"The task force on heart failure of the European Society of Cardiology","volume":"16","author":"Guidelines for the diagnosis of heart failure","year":"1995","journal-title":"Eur Heart J"},{"key":"2025071421513865600_zwaf371-B28","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/euhj.2000.2305","article-title":"Myocardial infarction redefined\u2013a consensus document of The Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction","volume":"21","year":"2000","journal-title":"Eur Heart J"},{"key":"2025071421513865600_zwaf371-B29","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"2025071421513865600_zwaf371-B30","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/circ.104.17.2118","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with atrial fibrillation: executive summary a report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines and policy conferences (committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American society of pacing and electrophysiology","volume":"104","author":"Fuster","year":"2001","journal-title":"Circulation"},{"key":"2025071421513865600_zwaf371-B31","doi-asserted-by":"crossref","first-page":"e14371","DOI":"10.1111\/eci.14371","article-title":"Residual risk prediction in anticoagulated patients with atrial fibrillation using machine learning: a report from the GLORIA-AF registry phase II\/III","volume":"55","author":"Liu","year":"2025","journal-title":"Eur J Clin Invest"},{"key":"2025071421513865600_zwaf371-B32","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2025071421513865600_zwaf371-B33","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0140-6736(16)30968-0","article-title":"Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study","volume":"388","author":"Healey","year":"2016","journal-title":"Lancet"},{"key":"2025071421513865600_zwaf371-B34","doi-asserted-by":"crossref","first-page":"e021566","DOI":"10.1161\/JAHA.121.021566","article-title":"Research priorities in the secondary prevention of atrial fibrillation: a national heart, lung, and blood institute virtual workshop report","volume":"10","author":"Benjamin","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2025071421513865600_zwaf371-B35","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1056\/NEJMoa2407105","article-title":"Asundexian versus apixaban in patients with atrial fibrillation","volume":"392","author":"Piccini","year":"2025","journal-title":"N Engl J Med"},{"key":"2025071421513865600_zwaf371-B36","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/europace\/euaa253","article-title":"Quality indicators for the care and outcomes of adults with atrial fibrillation: task force for the development of quality indicators in atrial fibrillation of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC): developed in collaboration with the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS)","volume":"23","author":"Arbelo","year":"2020","journal-title":"EP Europace"},{"key":"2025071421513865600_zwaf371-B37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"2025071421513865600_zwaf371-B38","doi-asserted-by":"crossref","first-page":"e012832","DOI":"10.1136\/bmjopen-2016-012832","article-title":"Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study","volume":"6","author":"Sundboll","year":"2016","journal-title":"BMJ Open"},{"key":"2025071421513865600_zwaf371-B39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000102143","article-title":"Validity of stroke diagnoses in a National Register of Patients","volume":"28","author":"Krarup","year":"2007","journal-title":"Neuroepidemiology"},{"key":"2025071421513865600_zwaf371-B40","first-page":"A5470","article-title":"The validity of the diagnosis of heart failure (I50.0-I50.9) in the Danish National Patient Register","volume":"65","author":"Delekta","year":"2018","journal-title":"Dan Med J"},{"key":"2025071421513865600_zwaf371-B41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2013.284692","article-title":"Smoking prevalence and cigarette consumption in 187 countries, 1980\u20132012","volume":"311","author":"Ng","year":"2014","journal-title":"JAMA"},{"key":"2025071421513865600_zwaf371-B42","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"2025071421513865600_zwaf371-B43","doi-asserted-by":"crossref","first-page":"iv50","DOI":"10.1093\/eurheartjsupp\/suae073","article-title":"Social drivers in atrial fibrillation occurrence, screening, treatment, and outcomes: systematic-narrative hybrid review","volume":"26","author":"Frost","year":"2024","journal-title":"Eur Heart J Suppl"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf371\/63581355\/zwaf371.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf371\/63581355\/zwaf371.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T01:51:47Z","timestamp":1752544307000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article\/doi\/10.1093\/eurjpc\/zwaf371\/8173891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":43,"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwaf371","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"article-number":"zwaf371"}}